Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
Mohamed Mahdi-Rogers, Yusuf A RajaballyNeuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester, UKAbstract: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired heterogeneous disorder of immune origin affecting the peripheral nerves, causing mot...
Main Authors: | Mohamed Mahdi-Rogers, Yusuf A Rajabally |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-03-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/overview-of-the-pathogenesis-and-treatment-of-chronic-inflammatory-dem-a4044 |
Similar Items
-
Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
by: Yusuf A Rajabally
Published: (2015-01-01) -
Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
by: Rajabally YA, et al.
Published: (2020-09-01) -
Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy
by: Anthony Khoo, et al.
Published: (2019-02-01) -
Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
by: Campbell Kaitryn, et al.
Published: (2010-06-01) -
Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US
by: Guptill JT, et al.
Published: (2019-04-01)